Bioequivalence ANDA SNP Clinical Study - Raloxifene and Single Nucleotide Polymorphisms
Clinical trial NCT06062810 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06062810
- Sponsor
- Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-21
- Primary completion
- 2026-12-18
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.